2018-2023 Global Eosinophilic Esophagitis Drug Consumption Market Report

August 2018 | 165 pages | ID: 2F4951FBB7AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Eosinophilic Esophagitis Drug market for 2018-2023.

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.

This report studies the eosinophilic esophagitis drug market.
The classification of eosinophilic esophagitis drug includes budesonide, fluticasone and other types, and the proportion of budesonide in 2017 is about 52%.
North America is the largest consumption region of eosinophilic esophagitis drug, with a sales market share nearly 32% in 2017. Europe is the second largest consumption region of eosinophilic esophagitis drug, enjoying Sales market share nearly 29% in 2017.
Market competition is intense. AstraZeneca, GSK, Bayer are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Over the next five years, LPI(LP Information) projects that Eosinophilic Esophagitis Drug will register a 6.2% CAGR in terms of revenue, reach US$ 150 million by 2023, from US$ 100 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Eosinophilic Esophagitis Drug market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Budesonide
• Fluticasone
• Others

Segmentation by application:

• Hospitals
• Clinics
• Drugstore

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• AstraZeneca
• GSK
• Bayer
• Adare Pharmaceuticals
• DBV Technologies
• Dr. Falk Pharma
• Quorum Innovations
• Shire
• Calypso
• Celgene
• Regeneron

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Eosinophilic Esophagitis Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Eosinophilic Esophagitis Drug market by identifying its various subsegments.
• Focuses on the key global Eosinophilic Esophagitis Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Eosinophilic Esophagitis Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Eosinophilic Esophagitis Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Eosinophilic Esophagitis Drug Consumption 2013-2023
  2.1.2 Eosinophilic Esophagitis Drug Consumption CAGR by Region
2.2 Eosinophilic Esophagitis Drug Segment by Type
  2.2.1 Budesonide
  2.2.2 Fluticasone
  2.2.3 Others
2.3 Eosinophilic Esophagitis Drug Consumption by Type
  2.3.1 Global Eosinophilic Esophagitis Drug Consumption Market Share by Type (2013-2018)
  2.3.2 Global Eosinophilic Esophagitis Drug Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Eosinophilic Esophagitis Drug Sale Price by Type (2013-2018)
2.4 Eosinophilic Esophagitis Drug Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Drugstore
2.5 Eosinophilic Esophagitis Drug Consumption by Application
  2.5.1 Global Eosinophilic Esophagitis Drug Consumption Market Share by Application (2013-2018)
  2.5.2 Global Eosinophilic Esophagitis Drug Value and Market Share by Application (2013-2018)
  2.5.3 Global Eosinophilic Esophagitis Drug Sale Price by Application (2013-2018)

3 GLOBAL EOSINOPHILIC ESOPHAGITIS DRUG BY PLAYERS

3.1 Global Eosinophilic Esophagitis Drug Sales Market Share by Players
  3.1.1 Global Eosinophilic Esophagitis Drug Sales by Players (2016-2018)
  3.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Players (2016-2018)
3.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Players
  3.2.1 Global Eosinophilic Esophagitis Drug Revenue by Players (2016-2018)
  3.2.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Players (2016-2018)
3.3 Global Eosinophilic Esophagitis Drug Sale Price by Players
3.4 Global Eosinophilic Esophagitis Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Eosinophilic Esophagitis Drug Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Eosinophilic Esophagitis Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 EOSINOPHILIC ESOPHAGITIS DRUG BY REGIONS

4.1 Eosinophilic Esophagitis Drug by Regions
  4.1.1 Global Eosinophilic Esophagitis Drug Consumption by Regions
  4.1.2 Global Eosinophilic Esophagitis Drug Value by Regions
4.2 Americas Eosinophilic Esophagitis Drug Consumption Growth
4.3 APAC Eosinophilic Esophagitis Drug Consumption Growth
4.4 Europe Eosinophilic Esophagitis Drug Consumption Growth
4.5 Middle East & Africa Eosinophilic Esophagitis Drug Consumption Growth

5 AMERICAS

5.1 Americas Eosinophilic Esophagitis Drug Consumption by Countries
  5.1.1 Americas Eosinophilic Esophagitis Drug Consumption by Countries (2013-2018)
  5.1.2 Americas Eosinophilic Esophagitis Drug Value by Countries (2013-2018)
5.2 Americas Eosinophilic Esophagitis Drug Consumption by Type
5.3 Americas Eosinophilic Esophagitis Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Eosinophilic Esophagitis Drug Consumption by Countries
  6.1.1 APAC Eosinophilic Esophagitis Drug Consumption by Countries (2013-2018)
  6.1.2 APAC Eosinophilic Esophagitis Drug Value by Countries (2013-2018)
6.2 APAC Eosinophilic Esophagitis Drug Consumption by Type
6.3 APAC Eosinophilic Esophagitis Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Eosinophilic Esophagitis Drug by Countries
  7.1.1 Europe Eosinophilic Esophagitis Drug Consumption by Countries (2013-2018)
  7.1.2 Europe Eosinophilic Esophagitis Drug Value by Countries (2013-2018)
7.2 Europe Eosinophilic Esophagitis Drug Consumption by Type
7.3 Europe Eosinophilic Esophagitis Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Eosinophilic Esophagitis Drug by Countries
  8.1.1 Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Eosinophilic Esophagitis Drug Value by Countries (2013-2018)
8.2 Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Type
8.3 Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Eosinophilic Esophagitis Drug Distributors
10.3 Eosinophilic Esophagitis Drug Customer

11 GLOBAL EOSINOPHILIC ESOPHAGITIS DRUG MARKET FORECAST

11.1 Global Eosinophilic Esophagitis Drug Consumption Forecast (2018-2023)
11.2 Global Eosinophilic Esophagitis Drug Forecast by Regions
  11.2.1 Global Eosinophilic Esophagitis Drug Forecast by Regions (2018-2023)
  11.2.2 Global Eosinophilic Esophagitis Drug Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Eosinophilic Esophagitis Drug Forecast by Type
11.8 Global Eosinophilic Esophagitis Drug Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 AstraZeneca
  12.1.1 Company Details
  12.1.2 Eosinophilic Esophagitis Drug Product Offered
  12.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 AstraZeneca News
12.2 GSK
  12.2.1 Company Details
  12.2.2 Eosinophilic Esophagitis Drug Product Offered
  12.2.3 GSK Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 GSK News
12.3 Bayer
  12.3.1 Company Details
  12.3.2 Eosinophilic Esophagitis Drug Product Offered
  12.3.3 Bayer Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Bayer News
12.4 Adare Pharmaceuticals
  12.4.1 Company Details
  12.4.2 Eosinophilic Esophagitis Drug Product Offered
  12.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Adare Pharmaceuticals News
12.5 DBV Technologies
  12.5.1 Company Details
  12.5.2 Eosinophilic Esophagitis Drug Product Offered
  12.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 DBV Technologies News
12.6 Dr. Falk Pharma
  12.6.1 Company Details
  12.6.2 Eosinophilic Esophagitis Drug Product Offered
  12.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Dr. Falk Pharma News
12.7 Quorum Innovations
  12.7.1 Company Details
  12.7.2 Eosinophilic Esophagitis Drug Product Offered
  12.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Quorum Innovations News
12.8 Shire
  12.8.1 Company Details
  12.8.2 Eosinophilic Esophagitis Drug Product Offered
  12.8.3 Shire Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Shire News
12.9 Calypso
  12.9.1 Company Details
  12.9.2 Eosinophilic Esophagitis Drug Product Offered
  12.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Calypso News
12.10 Celgene
  12.10.1 Company Details
  12.10.2 Eosinophilic Esophagitis Drug Product Offered
  12.10.3 Celgene Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Celgene News
12.11 Regeneron

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Eosinophilic Esophagitis Drug
Table Product Specifications of Eosinophilic Esophagitis Drug
Figure Eosinophilic Esophagitis Drug Report Years Considered
Figure Market Research Methodology
Figure Global Eosinophilic Esophagitis Drug Consumption Growth Rate 2013-2023 (K Units)
Figure Global Eosinophilic Esophagitis Drug Value Growth Rate 2013-2023 ($ Millions)
Table Eosinophilic Esophagitis Drug Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Budesonide
Table Major Players of Budesonide
Figure Product Picture of Fluticasone
Table Major Players of Fluticasone
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global Eosinophilic Esophagitis Drug Consumption Market Share by Type (2013-2018)
Figure Global Eosinophilic Esophagitis Drug Consumption Market Share by Type (2013-2018)
Table Global Eosinophilic Esophagitis Drug Revenue by Type (2013-2018) ($ million)
Table Global Eosinophilic Esophagitis Drug Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Eosinophilic Esophagitis Drug Value Market Share by Type (2013-2018)
Table Global Eosinophilic Esophagitis Drug Sale Price by Type (2013-2018)
Figure Eosinophilic Esophagitis Drug Consumed in Hospitals
Figure Global Eosinophilic Esophagitis Drug Market: Hospitals (2013-2018) (K Units)
Figure Global Eosinophilic Esophagitis Drug Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Eosinophilic Esophagitis Drug Consumed in Clinics
Figure Global Eosinophilic Esophagitis Drug Market: Clinics (2013-2018) (K Units)
Figure Global Eosinophilic Esophagitis Drug Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Eosinophilic Esophagitis Drug Consumed in Drugstore
Figure Global Eosinophilic Esophagitis Drug Market: Drugstore (2013-2018) (K Units)
Figure Global Eosinophilic Esophagitis Drug Market: Drugstore (2013-2018) ($ Millions)
Figure Global Drugstore YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Eosinophilic Esophagitis Drug Consumption Market Share by Application (2013-2018)
Figure Global Eosinophilic Esophagitis Drug Consumption Market Share by Application (2013-2018)
Table Global Eosinophilic Esophagitis Drug Value by Application (2013-2018)
Table Global Eosinophilic Esophagitis Drug Value Market Share by Application (2013-2018)
Figure Global Eosinophilic Esophagitis Drug Value Market Share by Application (2013-2018)
Table Global Eosinophilic Esophagitis Drug Sale Price by Application (2013-2018)
Table Global Eosinophilic Esophagitis Drug Sales by Players (2016-2018) (K Units)
Table Global Eosinophilic Esophagitis Drug Sales Market Share by Players (2016-2018)
Figure Global Eosinophilic Esophagitis Drug Sales Market Share by Players in 2016
Figure Global Eosinophilic Esophagitis Drug Sales Market Share by Players in 2017
Table Global Eosinophilic Esophagitis Drug Revenue by Players (2016-2018) ($ Millions)
Table Global Eosinophilic Esophagitis Drug Revenue Market Share by Players (2016-2018)
Figure Global Eosinophilic Esophagitis Drug Revenue Market Share by Players in 2016
Figure Global Eosinophilic Esophagitis Drug Revenue Market Share by Players in 2017
Table Global Eosinophilic Esophagitis Drug Sale Price by Players (2016-2018)
Figure Global Eosinophilic Esophagitis Drug Sale Price by Players in 2017
Table Global Eosinophilic Esophagitis Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Eosinophilic Esophagitis Drug Products Offered
Table Eosinophilic Esophagitis Drug Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Eosinophilic Esophagitis Drug Consumption by Regions 2013-2018 (K Units)
Table Global Eosinophilic Esophagitis Drug Consumption Market Share by Regions 2013-2018
Figure Global Eosinophilic Esophagitis Drug Consumption Market Share by Regions 2013-2018
Table Global Eosinophilic Esophagitis Drug Value by Regions 2013-2018 ($ Millions)
Table Global Eosinophilic Esophagitis Drug Value Market Share by Regions 2013-2018
Figure Global Eosinophilic Esophagitis Drug Value Market Share by Regions 2013-2018
Figure Americas Eosinophilic Esophagitis Drug Consumption 2013-2018 (K Units)
Figure Americas Eosinophilic Esophagitis Drug Value 2013-2018 ($ Millions)
Figure APAC Eosinophilic Esophagitis Drug Consumption 2013-2018 (K Units)
Figure APAC Eosinophilic Esophagitis Drug Value 2013-2018 ($ Millions)
Figure Europe Eosinophilic Esophagitis Drug Consumption 2013-2018 (K Units)
Figure Europe Eosinophilic Esophagitis Drug Value 2013-2018 ($ Millions)
Figure Middle East & Africa Eosinophilic Esophagitis Drug Consumption 2013-2018 (K Units)
Figure Middle East & Africa Eosinophilic Esophagitis Drug Value 2013-2018 ($ Millions)
Table Americas Eosinophilic Esophagitis Drug Consumption by Countries (2013-2018) (K Units)
Table Americas Eosinophilic Esophagitis Drug Consumption Market Share by Countries (2013-2018)
Figure Americas Eosinophilic Esophagitis Drug Consumption Market Share by Countries in 2017
Table Americas Eosinophilic Esophagitis Drug Value by Countries (2013-2018) ($ Millions)
Table Americas Eosinophilic Esophagitis Drug Value Market Share by Countries (2013-2018)
Figure Americas Eosinophilic Esophagitis Drug Value Market Share by Countries in 2017
Table Americas Eosinophilic Esophagitis Drug Consumption by Type (2013-2018) (K Units)
Table Americas Eosinophilic Esophagitis Drug Consumption Market Share by Type (2013-2018)
Figure Americas Eosinophilic Esophagitis Drug Consumption Market Share by Type in 2017
Table Americas Eosinophilic Esophagitis Drug Consumption by Application (2013-2018) (K Units)
Table Americas Eosinophilic Esophagitis Drug Consumption Market Share by Application (2013-2018)
Figure Americas Eosinophilic Esophagitis Drug Consumption Market Share by Application in 2017
Figure United States Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure United States Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure Canada Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure Canada Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure Mexico Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure Mexico Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Table APAC Eosinophilic Esophagitis Drug Consumption by Countries (2013-2018) (K Units)
Table APAC Eosinophilic Esophagitis Drug Consumption Market Share by Countries (2013-2018)
Figure APAC Eosinophilic Esophagitis Drug Consumption Market Share by Countries in 2017
Table APAC Eosinophilic Esophagitis Drug Value by Countries (2013-2018) ($ Millions)
Table APAC Eosinophilic Esophagitis Drug Value Market Share by Countries (2013-2018)
Figure APAC Eosinophilic Esophagitis Drug Value Market Share by Countries in 2017
Table APAC Eosinophilic Esophagitis Drug Consumption by Type (2013-2018) (K Units)
Table APAC Eosinophilic Esophagitis Drug Consumption Market Share by Type (2013-2018)
Figure APAC Eosinophilic Esophagitis Drug Consumption Market Share by Type in 2017
Table APAC Eosinophilic Esophagitis Drug Consumption by Application (2013-2018) (K Units)
Table APAC Eosinophilic Esophagitis Drug Consumption Market Share by Application (2013-2018)
Figure APAC Eosinophilic Esophagitis Drug Consumption Market Share by Application in 2017
Figure China Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure China Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure Japan Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure Japan Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure Korea Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure Korea Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure India Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure India Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure Australia Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure Australia Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Table Europe Eosinophilic Esophagitis Drug Consumption by Countries (2013-2018) (K Units)
Table Europe Eosinophilic Esophagitis Drug Consumption Market Share by Countries (2013-2018)
Figure Europe Eosinophilic Esophagitis Drug Consumption Market Share by Countries in 2017
Table Europe Eosinophilic Esophagitis Drug Value by Countries (2013-2018) ($ Millions)
Table Europe Eosinophilic Esophagitis Drug Value Market Share by Countries (2013-2018)
Figure Europe Eosinophilic Esophagitis Drug Value Market Share by Countries in 2017
Table Europe Eosinophilic Esophagitis Drug Consumption by Type (2013-2018) (K Units)
Table Europe Eosinophilic Esophagitis Drug Consumption Market Share by Type (2013-2018)
Figure Europe Eosinophilic Esophagitis Drug Consumption Market Share by Type in 2017
Table Europe Eosinophilic Esophagitis Drug Consumption by Application (2013-2018) (K Units)
Table Europe Eosinophilic Esophagitis Drug Consumption Market Share by Application (2013-2018)
Figure Europe Eosinophilic Esophagitis Drug Consumption Market Share by Application in 2017
Figure Germany Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure Germany Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure France Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure France Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure UK Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure UK Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure Italy Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure Italy Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure Russia Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure Russia Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure Spain Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure Spain Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Eosinophilic Esophagitis Drug Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Eosinophilic Esophagitis Drug Consumption Market Share by Countries in 2017
Table Middle East & Africa Eosinophilic Esophagitis Drug Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Eosinophilic Esophagitis Drug Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Eosinophilic Esophagitis Drug Value Market Share by Countries in 2017
Table Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Eosinophilic Esophagitis Drug Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Eosinophilic Esophagitis Drug Consumption Market Share by Type in 2017
Table Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Eosinophilic Esophagitis Drug Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Eosinophilic Esophagitis Drug Consumption Market Share by Application in 2017
Figure Egypt Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure Egypt Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure South Africa Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure South Africa Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure Israel Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure Israel Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure Turkey Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure Turkey Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Eosinophilic Esophagitis Drug Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Eosinophilic Esophagitis Drug Value Growth 2013-2018 ($ Millions)
Table Eosinophilic Esophagitis Drug Distributors List
Table Eosinophilic Esophagitis Drug Customer List
Figure Global Eosinophilic Esophagitis Drug Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Eosinophilic Esophagitis Drug Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Eosinophilic Esophagitis Drug Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Eosinophilic Esophagitis Drug Consumption Market Forecast by Regions
Table Global Eosinophilic Esophagitis Drug Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Eosinophilic Esophagitis Drug Value Market Share Forecast by Regions
Figure Americas Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Americas Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure APAC Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure APAC Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Europe Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Europe Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Middle East & Africa Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Middle East & Africa Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure United States Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure United States Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Canada Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Canada Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Mexico Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Mexico Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Brazil Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Brazil Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure China Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure China Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Japan Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Japan Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Korea Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Korea Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Southeast Asia Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Southeast Asia Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure India Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure India Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Australia Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Australia Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Germany Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Germany Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure France Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure France Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure UK Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure UK Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Italy Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Italy Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Russia Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Russia Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Spain Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Spain Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Egypt Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Egypt Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure South Africa Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure South Africa Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Israel Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Israel Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure Turkey Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure Turkey Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Figure GCC Countries Eosinophilic Esophagitis Drug Consumption 2018-2023 (K Units)
Figure GCC Countries Eosinophilic Esophagitis Drug Value 2018-2023 ($ Millions)
Table Global Eosinophilic Esophagitis Drug Consumption Forecast by Type (2018-2023) (K Units)
Table Global Eosinophilic Esophagitis Drug Consumption Market Share Forecast by Type (2018-2023)
Table Global Eosinophilic Esophagitis Drug Value Forecast by Type (2018-2023) ($ Millions)
Table Global Eosinophilic Esophagitis Drug Value Market Share Forecast by Type (2018-2023)
Table Global Eosinophilic Esophagitis Drug Consumption Forecast by Application (2018-2023) (K Units)
Table Global Eosinophilic Esophagitis Drug Consumption Market Share Forecast by Application (2018-2023)
Table Global Eosinophilic Esophagitis Drug Value Forecast by Application (2018-2023) ($ Millions)
Table Global Eosinophilic Esophagitis Drug Value Market Share Forecast by Application (2018-2023)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca Eosinophilic Esophagitis Drug Market Share (2016-2018)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GSK Eosinophilic Esophagitis Drug Market Share (2016-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bayer Eosinophilic Esophagitis Drug Market Share (2016-2018)
Table Adare Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Adare Pharmaceuticals Eosinophilic Esophagitis Drug Market Share (2016-2018)
Table DBV Technologies Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure DBV Technologies Eosinophilic Esophagitis Drug Market Share (2016-2018)
Table Dr. Falk Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Dr. Falk Pharma Eosinophilic Esophagitis Drug Market Share (2016-2018)
Table Quorum Innovations Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Quorum Innovations Eosinophilic Esophagitis Drug Market Share (2016-2018)
Table Shire Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shire Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Shire Eosinophilic Esophagitis Drug Market Share (2016-2018)
Table Calypso Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Calypso Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Calypso Eosinophilic Esophagitis Drug Market Share (2016-2018)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Celgene Eosinophilic Esophagitis Drug Market Share (2016-2018)
Table Regeneron Basic Information, Manufacturing Base, Sales Area and Its Competitors